Merck to create separate cancer division as Keytruda patent loss looms - Reuters
Merck to create separate cancer division as Keytruda patent loss looms Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxQU1BzQ29nR09oYWZJSTNRMW1wQy1uZHdPZmFvNGRYRk5LbUY0RWpkLXlfSjluMW9ubTJEUFZ1Ymc5ZHdrR2hxWEVud1VVdEI0ZkktREcyNW85ZFVPRHdHYnBlYnZ5aTM2ZlFsdGpCVU9WaE9lb29nd0VGdXlZeGVIYWYwZlRsT1RxOUp2akR1VWo3QVM4MWVOTEMtQnN6TmZfcHJ2X1p4TkdIcHpRUUpSMjJyTm8wSllOSDdpd2pvRlRKSG51azlSU0Y4TmhqeU9KM1R4NElVOEQ4TEpmaGhEZXpLUQ?oc=5" target="_blank">Merck to create separate cancer division as Keytruda patent loss looms</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Halozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMPfizer to cut around 330 jobs in Italy - Reuters
Pfizer to cut around 330 jobs in Italy Reuters
October 7, 2026 at 08:16 PMPharma lobby sues Trump administration over Medicare drug price cuts - Reuters
Pharma lobby sues Trump administration over Medicare drug price cuts Reuters
October 7, 2026 at 05:08 PMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PM